Peptide 101 | Azyven Research
KPV is a short peptide composed of three amino acids: lysine, proline, and valine. It corresponds to the C-terminal 11–13 sequence of alpha-melanocyte-stimulating hormone (α-MSH).
Despite its small size, KPV has been investigated in preclinical research involving inflammatory signaling, intestinal peptide transport, epithelial biology, and melanocortin-derived peptide activity.
What Is KPV?
KPV is the tripeptide Lys-Pro-Val. It is derived from the C-terminal region of α-MSH, a naturally occurring 13-amino-acid melanocortin peptide.
Research into truncated α-MSH sequences helped identify KPV as a small fragment with biological activity distinct from many of the pigment-related effects associated with the full-length peptide.
Much of the published KPV literature remains preclinical, including cell-culture experiments and animal models.
KPV and Alpha-MSH
Alpha-MSH participates in melanocortin signaling and has been investigated for immunomodulatory and anti-inflammatory activity.
KPV represents residues 11–13 of α-MSH. Studies comparing KPV with other α-MSH fragments suggest that its biological behavior does not simply reproduce the classical signaling of the full-length hormone.
This distinction has made KPV useful for investigating which biological effects may be retained within very short peptide sequences.
Research Into Inflammatory Signaling
A substantial portion of KPV research has examined inflammatory signaling in experimental systems.
Published studies have reported effects on pathways and mediators including NF-κB, MAP kinase signaling, inflammatory cytokines, and leukocyte migration under specific experimental conditions.
Importantly, these findings come largely from cellular and animal models. They establish research questions and mechanisms for investigation, not clinical efficacy in humans.
KPV and the PepT1 Transporter
One particularly interesting area of KPV research involves peptide transporter 1, commonly called PepT1.
PepT1 transports dipeptides and tripeptides across cell membranes. A 2008 Gastroenterology study reported that KPV could be transported through PepT1 in intestinal epithelial and immune-cell models and investigated the relationship between that transport and inflammatory signaling.
This makes KPV an example of how peptide research can involve not only receptors but also specialized transport proteins that influence how small peptides enter cells.
Intestinal Research Models
KPV has been investigated in several preclinical models of intestinal inflammation.
Researchers have studied KPV in chemically induced and immune-mediated mouse models of colitis, evaluating measurements such as inflammatory-cell infiltration, cytokine expression, histology, and other markers of experimental inflammation.
Later work also examined PepT1 and KPV in a mouse model of colitis-associated tumorigenesis.
These are preclinical findings in experimental models and should not be interpreted as evidence that KPV treats inflammatory bowel disease or cancer in humans.
Does KPV Act Through Melanocortin Receptors?
The precise signaling mechanisms associated with KPV remain an area of investigation.
Some experimental findings suggest that KPV's effects can occur independently of classical melanocortin receptor signaling. Other cell studies have examined possible interactions involving melanocortin pathways and intracellular calcium signaling.
Because results vary by experimental model, it is more accurate to describe KPV's mechanism as an active research question than to assign it a single established receptor mechanism.
Why KPV Is Scientifically Interesting
KPV demonstrates how a peptide containing only three amino acids can retain measurable biological activity and become a useful research tool.
Its relationship to α-MSH allows researchers to explore structure–activity relationships, while its small size makes it relevant to studies of peptide transport and cellular uptake.
Research areas associated with KPV include melanocortin-derived peptide biology, inflammatory signaling, intestinal epithelial biology, PepT1-mediated transport, and peptide structure–activity relationships.
From Sequence to Function
KPV also reinforces a recurring concept throughout Peptide 101: amino-acid sequence matters.
Reducing a 13-amino-acid peptide such as α-MSH to a three-amino-acid fragment changes its molecular structure substantially, yet selected biological activities can still be observed under experimental conditions.
Understanding which parts of a peptide contribute to particular molecular interactions is an important part of peptide structure–function research.
Continue Exploring
KPV connects naturally with several topics in the Azyven Research Library, including peptide sequence, receptors, cellular signaling, and peptide stability.
Continue exploring Peptide 101 and the Research Journal for additional science-focused explanations of peptide research.
Research today. A healthier tomorrow.
Explore KPV for Research
Interested in working with KPV in your laboratory research? View Azyven Research KPV →
Available strengths and product information can be found on the product page.
For laboratory research use only.
References
1. Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178. doi:10.1053/j.gastro.2007.10.026. PMID: 18061177.
2. Getting SJ, et al. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Journal of Pharmacology and Experimental Therapeutics. 2003. PMID: 12750433.
3. Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008. PMID: 18092346.
4. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, Haycock JW. Alpha-melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. Journal of Investigative Dermatology. 2004;122(4):1010–1019. doi:10.1111/j.0022-202X.2004.22404.x. PMID: 15102092.
5. Wuensch T, et al. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. PMID: 27458604.